ENPP1 Antikörper
-
- Target Alle ENPP1 Antikörper anzeigen
- ENPP1 (Ectonucleotide Pyrophosphatase/phosphodiesterase 1 (ENPP1))
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser ENPP1 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Kreuzreaktivität
- Human
- Produktmerkmale
-
Rabbit Polyclonal antibody to ENPP1 (ectonucleotide pyrophosphatase/phosphodiesterase 1)
ENPP1 antibody [N2C2], Internal - Aufreinigung
- Purified by antigen-affinity chromatography.
- Güteklasse
- KO Validated
- Immunogen
- Recombinant protein encompassing a sequence within the center region of human ENPP1. The exact sequence is proprietary.
- Isotyp
- IgG
- Top Product
- Discover our top product ENPP1 Primärantikörper
-
-
- Applikationshinweise
- WB: 1:500-1:3000. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.
- Kommentare
-
Positive Control: HepG2 , human liver
Validation: KO/KD, Overexpression
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.14 mg/mL
- Buffer
- 1XPBS ( pH 7), 1 % BSA, 20 % Glycerol, 0.025 % ProClin 300
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
-
Adipocytes promote malignant growth of breast tumours with monocarboxylate transporter 2 expression via β-hydroxybutyrate." in: Nature communications, Vol. 8, pp. 14706, (2018) (PubMed).
: "
-
Adipocytes promote malignant growth of breast tumours with monocarboxylate transporter 2 expression via β-hydroxybutyrate." in: Nature communications, Vol. 8, pp. 14706, (2018) (PubMed).
-
- Target
- ENPP1 (Ectonucleotide Pyrophosphatase/phosphodiesterase 1 (ENPP1))
- Andere Bezeichnung
- ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1 Produkte)
- Synonyme
- ENPP1 antikoerper, si:ch211-142e24.2 antikoerper, zgc:136238 antikoerper, ARHR2 antikoerper, M6S1 antikoerper, NPP1 antikoerper, NPPS antikoerper, PC-1 antikoerper, PCA1 antikoerper, PDNP1 antikoerper, 4833416E15Rik antikoerper, AI428932 antikoerper, C76301 antikoerper, CD203c antikoerper, E-NPP1 antikoerper, Ly-41 antikoerper, Npps antikoerper, Pca antikoerper, Pca-1 antikoerper, Pdnp1 antikoerper, ttw antikoerper, twy antikoerper, Pc1 antikoerper, ectonucleotide pyrophosphatase/phosphodiesterase 1 antikoerper, ectonucleotide pyrophosphatase/phosphodiesterase 1 L homeolog antikoerper, ENPP1 antikoerper, enpp1 antikoerper, enpp1.L antikoerper, Enpp1 antikoerper
- Hintergrund
-
This gene is a member of the ecto-nucleotide pyrophosphatase/phosphodiesterase (ENPP) family. The encoded protein is a type II transmembrane glycoprotein comprising two identical disulfide-bonded subunits. This protein has broad specificity and cleaves a variety of substrates, including phosphodiester bonds of nucleotides and nucleotide sugars and pyrophosphate bonds of nucleotides and nucleotide sugars. This protein may function to hydrolyze nucleoside 5' triphosphates to their corresponding monophosphates and may also hydrolyze diadenosine polyphosphates. Mutations in this gene have been associated with 'idiopathic' infantile arterial calcification, ossification of the posterior longitudinal ligament of the spine (OPLL), and insulin resistance.
- Molekulargewicht
- 105 kDa
- Gen-ID
- 5167
- UniProt
- P22413
- Pathways
- Regulation of Carbohydrate Metabolic Process
-